从恒瑞、协和麒麟看医药创新的残酷AB面

药视声Medispace
Mar 05

▲ 定档2026年5月29-30日苏州!精益智造·链接全球:2026中国制药产业大会重磅官宣!三月伊始,医药行业的棋盘上,几乎同时落下了两颗风格迥异的棋子。一边,恒瑞医药以一份“零意外”的董事会名单,上演了“全家福”般的稳定剧情。创始人孙飘扬携核心班底全数留任,宛如巨轮在既定航道上平稳前行。另一边,日本协和麒麟宣布全面终止rocatinlimab的所有临床试验。直接原因是临床试验中出现新增的确诊及...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10